Claudius Micha Nübling

Claudius Micha Nübling

Auto-generated profile, based on publicly available information

Claudius Micha Nübling

Paul Ehrlich Institut, Langen, Germany

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2021 in Eurosurveillance
Verified
Journal Article
Open access
HSHeinrich Scheiblauer
Heinrich Scheiblauer
AFAngela Filomena
Angela Filomena
ANAndreas Nitsche
Andreas Nitsche
APAndreas Puyskens
Andreas Puyskens
VCVictor M Corman
Victor M Corman
CNC Micha Nübling
C Micha Nübling
Introduction: Numerous CE-marked SARS-CoV-2 antigen rapid diagnostic tests (Ag RDT) are offered in Europe, several of them with unconfirmed quality claims. Aim: We performed an independent head-to-head evaluation of the sensitivity of SARS-CoV-2 Ag RDT offered in Germany. Methods: We addressed the sensitivity of 122 Ag RDT in direct comparison using a common evaluation panel comprised of 50 specimens. Minimum sensitivity of 75% for panel specimens with a PCR quantification cycle (Cq) ≤ 25 was used to identify Ag RDT eligible for reimbursement in the German healthcare system. Results: The sensitivity of different SARS-CoV-2 Ag RDT varied over a wide range. The sensitivity limit of 75% for panel members with Cq ≤ 25 was met by 96 of the 122 tests evaluated; 26 tests exhibited lower sensitivity, few of which failed completely. Some RDT exhibited high sensitivity, e.g. 97.5 % for Cq < 30. Conclusions: This comparative evaluation succeeded in distinguishing less sensitive from better performing Ag RDT. Most of the evaluated Ag RDT appeared to be suitable for fast identification of acute infections associated with high viral loads. Market access of SARS-CoV-2 Ag RDT should be based on minimal requirements for sensitivity and specificity.

28 August 2002 in Transfusion
Verified
Journal Article
Closed access
PDF file
CNC. Micha Nübling
C. Micha Nübling
GUGabriele Unger
Gabriele Unger
MCMichael Chudy
Michael Chudy
SRSteven Raia
Steven Raia
JLJohannes Löwer
Johannes Löwer

26 August 2009 in Transfusion
Verified
Journal Article
Closed access
PDF file
CNC. Micha Nübling
C. Micha Nübling
MHMargarethe Heiden
Margarethe Heiden
MCMichael Chudy
Michael Chudy
JKJulia Kress
Julia Kress
RSRainer Seitz
Rainer Seitz
MFMarkus B. Funk
Markus B. Funk

1 January 2019 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
SBS A Baylis
S A Baylis
PWP Wallace
P Wallace
EME McCulloch
E McCulloch
HNH G M Niesters
H G M Niesters
CNC M Nübling
C M Nübling
The first World Health Organization (WHO) international standards (ISs) for nucleic acid amplification techniques were established two decades ago, with the initial focus on blood screening for three major viral targets, i.e., hepatitis C virus, hepatitis B virus, and human immunodeficiency virus 1. These reference materials have subsequently found utility in the diagnosis and monitoring of a wide range of infectious diseases in clinical microbiology laboratories worldwide.

2 August 2011 in Transfusion
Verified
Journal Article
Closed access
PDF file
MCMichael Chudy
Michael Chudy
MWMarijke Weber‐Schehl
Marijke Weber‐Schehl
LPLutz Pichl
Lutz Pichl
CJChristine Jork
Christine Jork
JKJulia Kress
Julia Kress
CNC. Micha Nübling
C. Micha Nübling

1 January 1996 in The Lancet
Verified
Journal Article
Open access
CNC.M. Nübling
C.M. Nübling
JǑJ. L Ǒwer
J. L Ǒwer